Ozden Rabia Gurses has filed 20 insider transactions across 2 companies since January 2024.
Most recent transaction: a transaction of 85000 shares of Adverum Biotechnologies, Inc. ($ADVM) on December 09, 2025.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Ozden Rabia Gurses | Chief Medical Officer | U | Common Stock - Performance Stock Units | 85000 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.36% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Ozden Rabia Gurses | Chief Medical Officer | D | Stock Option (Right to Buy) | 48750 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.21% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Ozden Rabia Gurses | Chief Medical Officer | D | Stock Option (Right to Buy) | 44010 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.19% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Ozden Rabia Gurses | Chief Medical Officer | D | Stock Option (Right to Buy) | 85000 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.36% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Ozden Rabia Gurses | Chief Medical Officer | D | Stock Option (Right to Buy) | 4000 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.02% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Ozden Rabia Gurses | Chief Medical Officer | D | Stock Option (Right to Buy) | 8000 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.03% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Ozden Rabia Gurses | Chief Medical Officer | U | Common Stock - Restricted Stock Units | 8125 | $0.00 | 0.0000 | 23,487,000 | 100.00% | 0.03% |
| Dec. 9, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Ozden Rabia Gurses | Chief Medical Officer | A | Common Stock - Performance Stock Units | 85000 | $0.00 | 85,000.0000 | 23,487,000 | 9999.99% | 0.36% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Ozden Rabia Gurses | Chief Medical Officer | D | Stock Option (Right to Buy) | 8000 | $0.00 | 0.0000 | 19,782,000 | 100.00% | 0.04% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Ozden Rabia Gurses | Chief Medical Officer | A | Stock Option (Right to Buy) | 8000 | $0.00 | 8,000.0000 | 19,782,000 | 9999.99% | 0.04% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Ozden Rabia Gurses | Chief Medical Officer | D | Stock Option (Right to Buy) | 4000 | $0.00 | 0.0000 | 19,782,000 | 100.00% | 0.02% |
| June 17, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Ozden Rabia Gurses | Chief Medical Officer | A | Stock Option (Right to Buy) | 4000 | $0.00 | 4,000.0000 | 19,782,000 | 9999.99% | 0.02% |
| Feb. 25, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Ozden Rabia Gurses | Chief Medical Officer | A | Common Stock | 8125 | $0.00 | 8,125.0000 | 19,782,000 | 9999.99% | 0.04% |
| Feb. 25, 2025 | Adverum Biotechnologies, Inc. | $ADVM | Ozden Rabia Gurses | Chief Medical Officer | A | Stock Option (Right to Buy) | 48750 | $0.00 | 48,750.0000 | 19,782,000 | 9999.99% | 0.25% |
| Aug. 2, 2024 | Adverum Biotechnologies, Inc. | $ADVM | Ozden Rabia Gurses | Chief Medical Officer | A | Stock Option (Right to Buy) | 44010 | $0.00 | 44,010.0000 | 20,852,000 | 9999.99% | 0.21% |
| June 17, 2024 | Adverum Biotechnologies, Inc. | $ADVM | Ozden Rabia Gurses | Chief Medical Officer | A | Stock Option (Right to Buy) | 85000 | $0.00 | 85,000.0000 | 16,479,000 | 9999.99% | 0.52% |
| Feb. 3, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Ozden Rabia Gurses | Chief Medical Officer | A | Common Stock | 66633 | $0.00 | 159,400.0000 | 85,596,594 | 71.83% | 0.08% |
| Feb. 3, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Ozden Rabia Gurses | Chief Medical Officer | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 85,596,594 | 9999.99% | 0.23% |
| Feb. 5, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Ozden Rabia Gurses | Chief Medical Officer | S | Common Stock | 6346 | $4.86 | 153,054.0000 | 85,596,594 | 4.33% | 0.01% |
| Jan. 31, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Ozden Rabia Gurses | Chief Medical Officer | S | Common Stock | 7764 | $4.95 | 92,767.0000 | 85,596,594 | 7.72% | 0.01% |